About LifeMap Sciences
LifeMap Sciences (“LifeMap”) is a life sciences technology company dedicated to providing the leading edge Integrated Biomedical Knowledgebase. Operations worldwide are carried out from its offices in California, Massachusetts, New York, Tel Aviv and Hong Kong. LifeMap is a subsidiary of BioTime, Inc
LifeMap’s Integrated Biomedical Knowledgebase and discovery platform for biomedical research currently includes GeneCards®: the leading human gene database; LifeMap Discovery™, the database of embryonic development, stem cell research and regenerative medicine; and MalaCards, the human disease database. LifeMap’s products are used in more than 3,000 institutions including academia, research hospitals, patent offices, and leading biotechnology and pharmaceutical companies. LifeMap is also engaged in therapeutics discovery, utilizing LifeMap’s proprietary platform to aid in the development of products for the treatment of degenerative diseases, including utilizing BioTime’s proprietary, PureStem™ human progenitor cell lines.
In addition to its currently marketed products, LifeMap is pursuing several new internet and informatics products with substantial rapid revenue growth potential, leveraging its existing products and their large user base.
The new release includes extensive, detailed searchable information on more than 250 stem cell-based therapeutic approaches in research,
preclinical, clinical stages as well as marketed products, available via Premium access; high throughput experiments from MGI,
GENSAT and Hudsen in addition to already existing Euroexpress, GUDMAP, Human protein atlas, Homer, Tiger, Barcode and experiments
extracted from the literature and GEO; the addition of related stem cells, differentiation protocols and cell therapies to organs and tissue cards;
coverage of the development of the dermis; grouping of in vitro cells with common origin, mode of derivation and/or molecular characteristics;
and more comprehensive coverage of differentiation protocols.
Dec 06, 2013
LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.11
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.11. The new release is available at http://genecards.org. GeneCards ® is a comprehensive online database that provides comprehensive information on all human genes. It is accessed by professionals in many institutions including academia, research hospitals, patent offices, and leading biotech and pharma companies. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.